From October 1, 2022 to October 15, 2022, the company has repurchased 0 shares, representing 0% for KRW 0 million. With this, the company has completed the repurchase of 160,533 shares, representing 1.35% for KRW 19,650.63 million under the buyback announced on October 15, 2020.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
95,800 KRW | +1.27% |
|
-6.17% | -26.81% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-26.81% | 892M | |
+20.04% | 43.29B | |
+27.64% | 22.38B | |
+19.29% | 15.51B | |
+19.25% | 14.52B | |
+57.14% | 12.93B | |
-0.05% | 6.79B | |
-11.39% | 6.56B | |
+17.73% | 5.87B | |
-8.87% | 5.73B |
- Stock Market
- Equities
- A185750 Stock
- News Chong Kun Dang Pharmaceutical Corp.
- Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on October 15, 2020.